CLDX

Celldex Therapeutics, Inc.

34.80 USD
-0.58 (-1.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Celldex Therapeutics, Inc. stock is down -5.95% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 31.43% of the previous 34 May’s closed higher than April. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Apr 14:28 21 Jun, 2024 40.00 CALL 268 0
06 May 14:49 17 Jan, 2025 45.00 PUT 200 12
07 May 19:43 17 May, 2024 30.00 CALL 20 214
10 May 15:06 17 Jan, 2025 50.00 CALL 100 82
15 May 14:06 17 May, 2024 30.00 CALL 27 147

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27.

  • HC Wainwright & Co.
    Wed May 15, 10:39
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 7, 06:53
    buy
    confirm